Through KMPlotter, the prognostic value of VEGFR3 was assessed in a cohort of 131 BC basal patients treated with chemotherapy: high expression of the gene was statistically correlated with low relapse-free survival (p = 0.00081), thus suggesting VEGFR3 as a bad prognostic factor (Figure 3B). The gene discussed is FLT4; the disease is breast cancer.